...
首页> 外文期刊>GaBi journal. >How do regional sickness funds encourage more rational use of medicines, including the increase of generic uptake? A case study from Austria
【24h】

How do regional sickness funds encourage more rational use of medicines, including the increase of generic uptake? A case study from Austria

机译:区域疾病基金如何鼓励更多的合理使用药物,包括泛型摄取的增加?奥地利的案例研究

获取原文
           

摘要

Objective: To analyse similarities and differences between activities carried out by Austrian sickness funds to encourage more rational use of medicines, including increasing generics uptake.Methods: Semi-structured interviews with pharmacoeconomic unit staff of four regional sickness funds in Austria.Results: Sickness funds include a variety of activities. The main target group is prescribers, who are provided information and educational materials, and whose prescription patterns are monitored. All surveyed sickness funds encourage doctors to prescribe more generics as part of an overall strategy to improved rational prescribing. Sickness funds provide patient information; however, pharmacists are not considered to be a target group. In recent years, sickness funds responsible for primary care have launched joint initiatives with hospitals, e.g. training of hospital staff, with the aim of improving pharmacotherapy at the interface between outpatient (ambulatory) and hospital care.Discussion: All surveyed sickness funds carry out similar activities; however, the design of the individual measures differs between them as they have been adapted to meet regional differences.Conclusion: Sickness funds have initiated a number of regional activities. The effect of these activities could be reinforced if national policies were in place to support them. Examples include generics substitution and International Nonproprietary Name prescribing, regular analysis and publication of pharmaceutical spending and consumption, and improvement of pharmacotherapy at the interface between outpatient and hospital care.Submitted: 28 February 2013; Revised: 5 June 2013; Accepted: 7 June 2013; Published online first: 21 June 2013IntroductionRational use of medicines should ensure that patients receive ‘medications appropriate to their clinical needs, in doses that meet their own individual requirements for an adequate period of time, and at the lowest cost to them and their community’ [1]. Core policies defined by World Health Organization (WHO) to promote rational use of medicines [2] include clinical guidelines, essential medicines lists, Drug and Therapeutics Committees (DTC), training in undergraduate curricula and continuing medical education, independent information on medicines and public education, avoidance of perverse financial incentives, and sufficient and sustainable government expenditure.All European Union (EU) and European Economic Area (EEA) countries have reimbursement lists in place, usually in the form of positive lists [3–6], and Drug and Therapeutic Committees are a standard feature in European hospitals [7]. Public education programmes have been introduced in some countries [8], such as the antibiotics campaign in France [9] and the generics campaigns in France and Portugal [10–13].Rational use of medicines, however, continues to be a challenge in many countries, including European countries [14]. The European Surveillance of Antibiotic Consumption project showed over- and misuse of antibiotics in European countries, with wide variation in type and volume of antibiotics prescribed [15]. Despite several interventions, patient adherence to medication remains poor [16–20]. Generic medicines help reduce the costs incurred by public payers [6, 21] and are, in accordance with the WHO Nairobi declaration [1], a way of supporting rational use of medicines. It seems, however, that generics policies are not fully exploited in some European countries [22–25]. Policies to promote generics uptake, which is defined as the increase in the use of generics compared with the originator or patent medicines within a substitutable class, include the promotion of generics substitution at all levels of the health system, and the promotion of generics acceptance by professionals, patients, and the general community [26–28].Austria’s healthcare systemAustria’s healthcare system is based on a social security system with compulsory insurance. The social in
机译:目的:分析奥地利疾病资金开展的活动的相似之处和差异,鼓励更多的合理使用药物,包括增加泛型的普遍使用。奥地利四个区域疾病基金的药物经济单位员工的半结构化访谈。结果:疾病资金包括各种活动。主要目标集团是处方,提供信息和教育材料,并监测其处方模式。所有受调查的疾病基金都鼓励医生在改善理性处方提高整体战略的一部分中规定更多泛型。疾病资金提供患者信息;但是,药剂师不被认为是目标群体。近年来,负责初级护理的疾病基金启动了与医院的联合举措,例如,医院工作人员的培训,目的是在门诊(动态)和医院护理之间的界面处改善药物疗法。探讨:所有调查的疾病资金都开展类似的活动;然而,各种措施的设计与它们之间的不同之处在于它们适应区域差异。结论:疾病基金已启动许多区域活动。如果国家政策适当地支持它们,可以加强这些活动的效果。例子包括泛型替代和国际非专业名称,经常分析和出版药品支出和消费,以及在门诊和医院护理之间的界面上的药物治疗。分配:2013年2月28日;修订:2013年6月5日;接受:2013年6月7日;首先发布于网上:2013年6月21日突发性使用药物应确保患者接受适合其临床需求的药物,以适当的一段时间,并以最低的成本及其社区的成本及其社区的最低成本1]。世界卫生组织(世卫组织)促进合理使用药物的核心政策[2]包括临床指南,基本药物名单,药物和治疗委员会(DTC),本科课程培训以及继续医学教育,有关药物和公众的独立信息教育,避免经济奖励,充分和可持续的政府支出。所有欧盟(欧盟)和欧洲经济区(EEA)国家有报销列表,通常以正面清单[3-6]和药物和治疗委员会是欧洲医院的标准特征[7]。一些国家介绍了公共教育计划[8],例如法国的抗生素运动[9]以及法国和葡萄牙的普通竞选[10-13]。然而,普遍使用药物的使用仍然是一个挑战许多国家,包括欧洲国家[14]。欧洲抗生素消费项目监测显示欧洲国家的抗生素过度和滥用,具有广泛的抗生素规定的抗生素的变化[15]。尽管有几次干预措施,患者依从药物仍然差[16-20]。通用药物有助于降低公共付款人所产生的成本[6,21],并按照WHO Nairobi宣言[1],这是一种支持合理使用药物的方式。然而,似乎,在一些欧洲国家没有充分利用普遍剥削的政策[22-25]。促进泛型摄取的政策被定义为与可替代类别内的发起者或专利药物使用的使用增加,包括促进卫生系统各级的泛型替代,以及促进仿制性接受专业人士,患者和普通社会[26-28]。澳洲医疗保健系统的医疗保健系统是基于强制保险的社会保障制度。社交in.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号